Teleflex (NYSE:TFX) Share Price Crosses Above 200 Day Moving Average – Should You Sell?

Teleflex Incorporated (NYSE:TFX) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $119.99 and traded as high as $136.32. Teleflex shares last traded at $134.1630, with a volume of 531,427 shares changing hands.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on TFX. Wall Street Zen upgraded Teleflex from a “sell” rating to a “hold” rating in a report on Saturday, June 27th. Zacks Research upgraded shares of Teleflex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 28th. Bank of America upgraded Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price objective on the stock in a report on Monday, April 13th. Wells Fargo & Company increased their target price on shares of Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a report on Friday, May 8th. Finally, Royal Bank Of Canada raised Teleflex from a “sector perform” rating to an “outperform” rating and increased their price target for the company from $135.00 to $155.00 in a research report on Friday, May 8th. Five equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $147.44.

Teleflex Price Performance

The stock has a 50-day moving average price of $129.72 and a 200 day moving average price of $119.99. The firm has a market cap of $5.94 billion, a price-to-earnings ratio of -5.88, a PEG ratio of 0.97 and a beta of 0.82. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.55 and a quick ratio of 2.03.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, topping analysts’ consensus estimates of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The firm had revenue of $548.30 million during the quarter, compared to analysts’ expectations of $536.91 million. During the same quarter in the prior year, the business earned $1.44 EPS. Teleflex’s quarterly revenue was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities research analysts forecast that Teleflex Incorporated will post 6.7 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Monday, May 25th were given a $0.34 dividend. The ex-dividend date was Friday, May 22nd. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is presently -5.96%.

Institutional Investors Weigh In On Teleflex

Several institutional investors have recently made changes to their positions in TFX. Banque Cantonale Vaudoise grew its position in Teleflex by 82.5% during the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after buying an additional 113 shares during the period. V Square Quantitative Management LLC purchased a new position in Teleflex in the 4th quarter valued at about $37,000. UMB Bank n.a. grew its stake in Teleflex by 57.1% in the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock worth $38,000 after acquiring an additional 113 shares during the period. Sound Income Strategies LLC purchased a new stake in shares of Teleflex in the fourth quarter valued at $45,000. Finally, Kestra Advisory Services LLC acquired a new position in shares of Teleflex during the 4th quarter valued at about $45,000. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.